A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non–Small-Cell Lung Cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)
2015 ◽
Vol 10
(1)
◽
pp. 143-147
◽
Keyword(s):
Phase Ii
◽